Get the app!
Back to Trades

Rotunno Mary L.

DirectorCIK 0001869200

Largest Purchase

No open-market purchases in the recent filings.

Profile

Filings
1
Buy transactions
0
Sell transactions
0
Companies
1
Active
2025

Rotunno Mary L., Director, has filed 1 SEC report (2025), all concentrated in Vistagen Therapeutics, Inc. (VTGN), totaling $63.5K in disclosed volume. Data is sourced from official SEC Form 3, 4, and 5 filings.

Trading History

1 loaded
Sep 11VTGN
Vistagen Therapeutics, Inc.
Rotunno Mary L.DirectorAward$63.5K

1 filing